Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Receivables (2019 - 2025)

Historic Receivables for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $28.3 million.

  • Outset Medical's Receivables fell 2046.66% to $28.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $28.3 million, marking a year-over-year decrease of 2046.66%. This contributed to the annual value of $28.3 million for FY2025, which is 2046.66% down from last year.
  • According to the latest figures from Q4 2025, Outset Medical's Receivables is $28.3 million, which was down 2046.66% from $33.0 million recorded in Q3 2025.
  • Outset Medical's Receivables' 5-year high stood at $36.9 million during Q2 2023, with a 5-year trough of $12.1 million in Q1 2021.
  • In the last 5 years, Outset Medical's Receivables had a median value of $33.0 million in 2023 and averaged $29.4 million.
  • Per our database at Business Quant, Outset Medical's Receivables soared by 29579.47% in 2021 and then crashed by 2046.66% in 2025.
  • Quarter analysis of 5 years shows Outset Medical's Receivables stood at $25.6 million in 2021, then rose by 9.65% to $28.1 million in 2022, then rose by 17.49% to $33.0 million in 2023, then increased by 8.0% to $35.6 million in 2024, then dropped by 20.47% to $28.3 million in 2025.
  • Its last three reported values are $28.3 million in Q4 2025, $33.0 million for Q3 2025, and $34.9 million during Q2 2025.